Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Neonatal-Perinatal Physicians

Analysis of: Majority of Patients Want Doc to use EHRs: Study (www.modernhealthcare.com)
Just like expensive, do-everything end-of-life care, like unlimited imaging studies, like newest drugs, patients want it all. This is one of the attitudes which causes the US to spend far more than other developed countries for far less efficient and cost-effective health care.
August 5, 2008
TANSTAAFL
Analysis of: Just Sitting Back to Get in Shape: Two Pills Do teh Work of Exercise (online.wsj.com)
(There ain't no such thing as a free lunch.) Just like the electronic devices which claim to stimulate constant muscle contractions, these pills seem to produce increased muscle metabolic activity, making the muscle "think" that it has been exercising. The animals in the study had increased endurance...
Analysis of: Associations Between Exposure To Traffic-Related Air Pollution And The Onset Of Allergic Diseases In Children Shown By New Research (www.medicalnewstoday.com)
There is not much new here for those involved in clinical care of children, but it is good to have statistical support for what we have always taught about pollution and allergic disorders, especially asthma.
Analysis of: Intermittent tacrolimus Ointment therapy Helps Prevent Relapse Of Stabilized Atpoic Dermatitis (www.medscape.com)
Treatment of atopic dermatitis has always been frustrating. Flare-ups, which are all too common, can be treated with topical steroids, but these cannot be used for prolonged periods without significant downside. And lubrication of the skin, the mainstay of maintenance therapy, is not always effective...
Analysis of: Patients Curb Prescription Spending (online.wsj.com)
While the need for urgent care does not disappear during tough economic times, patients are far more selective about when they consider themselves sick enough to require medical care. With higher copayments, often $25-50, patients think twice before going to a physician for minor complaints--they might...
Analysis of: Drugs to Build Bones May Weaken Them (www.nytimes.com)
As in so many other instances, some potential side effects will only show up once the number of patients has grown far beyond the number studied in pre-marketing studies.
Analysis of: 8-Year-Olds on Statins? A New Plan Quickly Bites Back (www.nytimes.com)
While I am sure that there are a few children with hereditary lipid disorders which should be treated aggressively and early with statins, the data is certainly not available to support routine treatment of every child with elevated lipid values.
Analysis of: Taro Receives Final FDA Approval For RX Cetirizine Hydrochloride Syrup ANDA (www.medicalnewstoday.com)
If the same drug is available OTC, insurances won't cover the rx form, and patients will (continue to) self-treat with OTC meds, without even needing to see their doctor.
June 30, 2008
Who cares?
Analysis of: Taro Receives Final FDA Approval For RX Cetirizine Hydrochloride Syrup ANDA (www.medicalnewstoday.com)
Taro just got approval for Rx cetirizine - big whoop!  Zyrtec has been OTC in all forms (tablet, chewable and syrup) since 11/07.  Do you know anyone who will write a prescription for an OTC drug or an insurance company that will cover it?
Analysis of: FDA Approves GlaxoSmithKline's New Combination Vaccine For Children (www.medicalnewstoday.com)
Glaxo has just gotten approval for Kinrix (DTaP-IPV).  It's products for infants and toddlers, Pediarix (DTaP-HepB-IPV) and Infanrix (DTaP) are used in children under 2; Kinrix will be used for the 4-6 year booster dose, reducing by 1 the number of vacthat children get at this age.

Previous Page : 1 2 3 4 5 6 7 8 9 10 11 12 13 Next31 to 40 of 181

Analytics


Generated at 2009-01-07T07:00:32.297